U.S. Food and Drug Administration; United States Food and Drug Administration; FDA; Food and Drug Administration (FDA); Food and Drug Administration

The FDA is recommending that 7-hydroxymitragynine (7-OH), a synthetic, concentrated substance derived from kratom leaves, be classified as…

An FDA advisory panel has resoundingly rejected the supplemental new drug application for the atypical antipsychotic brexpiprazole (Rexulti,…